ARYA Sciences Acquisition Corp IV Stock Forecast, Price & News

Wall Street analysts have given ARYA Sciences Acquisition Corp IV a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ARYA Sciences Acquisition Corp IV wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Some companies that are related to ARYA Sciences Acquisition Corp IV include Ikena Oncology (IKNA), Adagene (ADAG), Custom Truck One Source (CTOS), Fifth Wall Acquisition Corp. I (FWAA), Lava Therapeutics B.V. (LVTX), SVF Investment Corp. 3 (SVFC), SVF Investment Corp. 2 (SVFB), Viveon Health Acquisition (VHAQ), PLBY Group (PLBY), Wunong Net Technology (WNW), HealthCor Catalio Acquisition (HCAQ), Gold Royalty (GROY), Research Alliance Corp. II (RACB), ABG Acquisition Corp. I (ABGI) and Vivos Therapeutics (VVOS).
View all of ARYD's competitors.

(ARYD) raised $130 million in an initial public offering (IPO) on Friday, February 26th 2021. The company issued 13,000,000 shares at a price of $10.00 per share. Goldman Sachs and Jefferies acted as the underwriters for the IPO.

ARYA Sciences Acquisition Corp IV trades on the NASDAQ under the ticker symbol "ARYD."

ARYA Sciences Acquisition Corp IV's lock-up period expires on Wednesday, August 25th. ARYA Sciences Acquisition Corp IV had issued 13,000,000 shares in its initial public offering on February 26th. The total size of the offering was $130,000,000 based on an initial share price of $10.00. After the expiration of ARYA Sciences Acquisition Corp IV's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of ARYD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ARYD stock can currently be purchased for approximately $10.89.

ARYA Sciences Acquisition Corp IV has a market capitalization of $181.97 million.